drugset / Trial / NCT00489307

Dexamethasone for Symptom Burden in Advanced Cancer Patients

NCT00489307 ↗

Phase 2 Active not recruiting 132 enrolled M.D. Anderson Cancer Center American Cancer Society, Inc. · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The goal of this clinical research study is to learn if dexamethasone can help to control symptoms such as fatigue, pain, nausea, weight loss, loss of appetite, sleep problems, and/or depression in patients with advanced cancer.

Timeline

Start
2006-02-02
Primary completion
2021-02-28
Completion
2028-02-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 4 mg Oral

Indications